Miragen Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.5M | 208k | 21.58 |
| 2025-06-30 | $3.2M | 231k | 13.98 |
| 2025-03-31 | $1.7M | 124k | 13.49 |
| 2024-12-31 | $3.0M | 158k | 19.18 |
| 2024-09-30 | $2.9M | 125k | 22.74 |
| 2024-06-30 | $765k | 59k | 13.00 |
| 2024-03-31 | $2.2M | 124k | 17.50 |
| 2023-12-31 | $4.8M | 220k | 21.78 |
| 2023-09-30 | $2.0M | 132k | 15.34 |
| 2023-06-30 | $6.1M | 258k | 23.79 |
| 2023-03-31 | $3.0M | 116k | 25.44 |
| 2022-12-31 | $2.9M | 99k | 29.21 |
| 2022-09-30 | $13M | 654k | 20.51 |
| 2022-06-30 | $212k | 18k | 11.58 |
| 2022-03-31 | $314k | 17k | 18.47 |